Clevidipine is a dihydropyridine calcium channel blocker used for the reduction of blood pressure when oral therapy is not feasible or desirable. It is administered intravenously and has a rapid onset and short duration of action. It is grouped under the following drug class(es): Calcium Channel Blockers and Vasodilating agents. Its therapeutic use is listed as antihypertensives and cardiovascular. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Cleviprex and Clevidepine. Its PubChem CID is 153994.
Clevidipine
| CAS No | 167221-71-8 |
|---|---|
| Molecular Formula | C21H23Cl2NO6 |
| Molecular Weight | 456.3 g/mol |
| Synonyms | (RS)-5-O-(Butanoyloxymethyl) 3-O-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Clevidipine is a dihydropyridine calcium channel blocker used for the reduction of blood pressure when oral therapy is not feasible or desirable. It is administered intravenously and has a rapid onset and short duration of action.
The listed CAS number is 167221-71-8.
The listed molecular formula is C21H23Cl2NO6.
The listed molecular weight is 456.3 g/mol.
(RS)-5-O-(Butanoyloxymethyl) 3-O-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate.
The source lists Cleviprex and Clevidepine.